What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
4.55%Above 5Y avg (2.41%)
Annual Rate
USD 0.64Paid quarterly
Payout Ratio
28.8%Sustainable
Paying Dividends
22 yr
Payback Period
17.1 yr
Last Ex-Dividend
Dec 26, 2025
Last Payment
Jan 9, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.81BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Revenue (TTM)
3.68BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Profit Margin
-17.06%
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Beta
0.8940x
vs all stocks
Updated Jul 19, 2026
52-Week Change
-10.11%
vs all stocks
Updated Jul 19, 2026
Forward Annual Dividend Yield
4.55%
vs all stocks
Updated Jul 19, 2026
Market Capitalization
2.81BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Enterprise Value
4.97BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Forward P/E
9.06x
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Price to Sales (TTM)
0.7646x
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Price to Book (MRQ)
2.09x
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Enterprise to Revenue
1.35x
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Enterprise to EBITDA
8.94x
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Gross Margin
48.52%
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Profit Margin
-17.06%
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Operating Margin
3.41%
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Return on Assets (TTM)
2.26%
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Return on Equity (TTM)
-37.67%
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Revenue (TTM)
3.68BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Revenue per Share (TTM)
18.44USDUpdated Jul 19, 2026
Quarterly Revenue Growth
0.10%
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Gross Profit (TTM)
1.80BUSD
vs all stocks (USD)
Updated Jul 19, 2026
EBITDA (TTM)
561.00MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Net Income (TTM)
-628.00MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Quarterly Earnings Growth (YoY)
0.11%
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Operating Cash Flow (TTM)
268.00MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Levered Free Cash Flow (TTM)
129.63MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Forward Annual Dividend Rate
0.6400USDUpdated Jul 19, 2026
Forward Annual Dividend Yield
4.55%
vs all stocks
Updated Jul 19, 2026
Trailing Annual Dividend Rate
0.6400USDUpdated Jul 19, 2026
Trailing Annual Dividend Yield
4.55%
vs all stocks
Updated Jul 19, 2026
5-Year Average Dividend Yield
2.41%
vs all stocks
Updated Jul 19, 2026
Payout Ratio
28.83%
vs Medical Instruments & Supplies peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives -20.32%.Updated Jul 19, 2026
Minority Interest (Equity)
1.00MUSDFY2025 · Dec 31, 2025
Revenue
3.68BUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
1.84BUSDFY2025 · Dec 31, 2025
Gross Profit
1.84BUSDFY2025 · Dec 31, 2025
Operating Income
252.00MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-486.00MUSDFY2025 · Dec 31, 2025
Income Tax Expense
112.00MUSDFY2025 · Dec 31, 2025
Net Income
-598.00MUSDFY2025 · Dec 31, 2025
EBIT
-398.00MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
596.00MUSDFY2025 · Dec 31, 2025
Research & Development
150.00MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
1.44BUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
88.00MUSDFY2025 · Dec 31, 2025
EPS (Basic)
-3.00USDFY2025 · Dec 31, 2025
EPS (Diluted)
-3.00USDFY2025 · Dec 31, 2025
Basic Shares Outstanding
199.40MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
199.40MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-598.00MUSDFY2025 · Dec 31, 2025
Minority Interests (P&L)
0.00USDFY2025 · Dec 31, 2025
Operating Cash Flow
-334.00MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
326.00MUSDFY2025 · Dec 31, 2025
Income Tax Paid
71.00MUSDFY2025 · Dec 31, 2025
Interest Paid
66.00MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-598.00MUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
352.00MUSDFY2025 · Dec 31, 2025
Deferred Taxes (CF)
30.00MUSDFY2025 · Dec 31, 2025
Stock-based Compensation
33.00MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
-10.00MUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-91.00MUSDFY2025 · Dec 31, 2025
Change in Accounts Payable (CF)
11.00MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-61.00MUSDFY2025 · Dec 31, 2025
Net Acquisitions
0.00USDFY2025 · Dec 31, 2025
Purchase of Investments
-14.00MUSDFY2025 · Dec 31, 2025
Sale of Investments
10.00MUSDFY2025 · Dec 31, 2025
Other Investing Activity
3.00MUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
-1.00MUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
553.00MUSDFY2025 · Dec 31, 2025
Long-term Debt Payments
-918.00MUSDFY2025 · Dec 31, 2025
Net Short-term Debt Issuance
-336.00MUSDFY2025 · Dec 31, 2025
Common Stock Repurchase
0.00USDFY2025 · Dec 31, 2025
Common Dividends Paid
-128.00MUSDFY2025 · Dec 31, 2025
Other Financing Charges
-22.00MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
-851.00MUSDFY2025 · Dec 31, 2025
Shares Outstanding
200.30MSharesUpdated Jul 19, 2026
Float Shares
199.22MSharesUpdated Jul 19, 2026
Shares Short
29.22MSharesUpdated Jul 19, 2026
Short Ratio
4.90days
vs all stocks
Updated Jul 19, 2026
Short % of Shares Outstanding
16.26%
vs all stocks
Updated Jul 19, 2026
% Held by Insiders
0.63%
vs all stocks
Updated Jul 19, 2026
% Held by Institutions
110.08%
vs all stocks
Updated Jul 19, 2026
Total Cash (MRQ)
190.00MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Total Cash per Share (MRQ)
0.9480USDUpdated Jul 19, 2026
Total Debt (MRQ)
2.34BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Total Debt to Equity (MRQ)
1.78x
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Current Ratio (MRQ)
1.53x
vs Medical Instruments & Supplies peers
Updated Jul 19, 2026
Book Value per Share (MRQ)
6.71USDUpdated Jul 19, 2026
Total Assets
5.43BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
2.02BUSDFY2025 · Dec 31, 2025
Total Liabilities
4.09BUSDFY2025 · Dec 31, 2025
Total Non-current Assets
3.41BUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
2.75BUSDFY2025 · Dec 31, 2025
Total Current Liabilities
1.34BUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
326.00MUSDFY2025 · Dec 31, 2025
Accounts Receivable
688.00MUSDFY2025 · Dec 31, 2025
Inventory
642.00MUSDFY2025 · Dec 31, 2025
Accounts Payable
300.00MUSDFY2025 · Dec 31, 2025
Short-term Debt
360.00MUSDFY2025 · Dec 31, 2025
Deferred Revenue
74.00MUSDFY2025 · Dec 31, 2025
Other Current Liabilities
30.00MUSDFY2025 · Dec 31, 2025
Long-term Debt
2.11BUSDFY2025 · Dec 31, 2025
Other Non-current Liabilities
544.00MUSDFY2025 · Dec 31, 2025
Common Stock (Book)
3.00MUSDFY2025 · Dec 31, 2025
Retained Earnings
-1.56BUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.34BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
3.10BUSDFY2025 · Dec 31, 2025
52-Week Low
9.41USDUpdated Jul 19, 2026
52-Week High
17.09USDUpdated Jul 19, 2026
52-Week Change
-10.11%
vs all stocks
Updated Jul 19, 2026
Beta
0.8940x
vs all stocks
Updated Jul 19, 2026
50-Day MA
10.78USDUpdated Jul 19, 2026
200-Day MA
11.75USDUpdated Jul 19, 2026
Avg 10-Day Volume
5.21MSharesUpdated Jul 19, 2026
Avg 30-Day Volume
5.78MSharesUpdated Jul 19, 2026
Diluted EPS (TTM)
-3.15USDUpdated Jul 19, 2026
Other Income / Expense
-650.00MUSDFY2025 · Dec 31, 2025
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Debt is a large share of its assets, and large against its cash flow.
Reads
Elevated Leverage on Three Denominators
Debt sits high against its equity, its assets, and its cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Return on equity is -37.7%, lower than 95% of its Medical Instruments & Supplies peers (median 5.6%)Significant
Return on equity: -0.38Industry median: 0.06Industry P5: -0.18Peers compared: 35.00
Debt-to-equity is 1.78×, higher than 95% of its Medical Instruments & Supplies peers (median 0.16×)Significant